This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Meiji Seika Pharma Co., Ltd.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Teruhisa Yoshizawa: Innovator in Injectable Solutions
Introduction
Teruhisa Yoshizawa is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of injectable solutions. His work has the potential to impact cancer treatment through innovative formulations.
Latest Patents
Yoshizawa holds a patent for an injectable solution and injection kit preparation. This patent includes an injectable comprising an anthracycline antineoplastic antibiotic and at least one acid amide selected from nicotinic acid amide, isonicotinic acid amide, and gentisic acid ethanolamide. This formulation aims to enhance the efficacy of cancer treatments.
Career Highlights
Yoshizawa is associated with Meiji Seika Pharma Co., Ltd., where he has been instrumental in advancing pharmaceutical innovations. His expertise in injectable solutions has positioned him as a key figure in the industry.
Collaborations
Yoshizawa has collaborated with notable colleagues, including Akiko Miyoshi and Masato Ota. Their combined efforts contribute to the ongoing research and development in the pharmaceutical sector.
Conclusion
Teruhisa Yoshizawa's work in injectable solutions exemplifies the innovative spirit of modern pharmaceutical research. His contributions are paving the way for advancements in cancer treatment and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile